Asterias Biotherapeutics Inc. Common Series A (AST) Climbed 5.33% or 0.04 To Price $0.79 On Tuesday


Asterias Biotherapeutics Inc. Common Series A (AST) climbed 5.33% or 0.04 to $0.79. It is near to 79471 shares traded, which is 32.99% compare to the average total volume 240874. The market cap of AST is $43.97 million. The year to date change is 15.63%. The 52 week price range is from $0.51 to $2.65. Price of AST have changed 20.97% during last week. It have changed -20.91% over last month, -38.02% over last 3 months, -48.28% over last 6 months and -68.09% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AST is 0.98. It is 24.05% above current price. The 200-day Moving Averages for AST is 1.38. It is 74.68% above current price. The 52-week High is 2.65. It is 235.44% from the current price. The 52-week Low is 0.51. It is -35.44% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AST is 2.75 on 2018-12-14. Short % to float is 1.13%. There are some statistics of AST. It is has market cap $43.97 million. The share outstanding is 55.66 million. The average volume is 240874. The percent of top 15 Institution holding is 19.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AST is -72.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AST is -55.84%.


Tags:

Share this post